Abstract
Among 5 patients with idiopathic diffuse interstitial disease and 16 patients with scleroderma, one with idiopathic pulmonary fibrosis died within six months of follow-up examination. Three others showed progressive deterioration of lung volumes and diffusing capacity and also died. One patient who had a relatively acute interstitial pneumonitis had remarkable clinical and functional remission with corticosteroid therapy. Of the 16 patients with scleroderma, 13 had evidence of interstitial fibrosis and 2 of peribronchial fibrosis. However, progressive reduction of lung volumes and diffusing capacity with time was seen in only three. Improvement with therapy was seen in two, while one patient's condition was thought to represent clearing of pleurisy, and the other's improvement of bronchial obstruction. Interstitial fibrosis in scleroderma appears to have a more indolent course than the idiopathic variety, but shows little or no response to treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
